Zorvolex FDA Approval History
FDA Approved: Yes (First approved October 18, 2013)
Brand name: Zorvolex
Generic name: diclofenac
Dosage form: Capsules
Company: Iroko Pharmaceuticals, LLC
Treatment for: Pain, Osteoarthritis
Zorvolex (diclofenac) is a nonsteroidal anti-inflammatory drug (NSAID) indicated for the treatment of mild to moderate acute pain, and for the management of osteoarthritis pain.
Development timeline for Zorvolex
| Date | Article |
|---|---|
| Aug 25, 2014 | Approval Iroko Pharmaceuticals Gains FDA Approval of Zorvolex for Management of Osteoarthritis Pain |
| Oct 18, 2013 | Approval Iroko Pharmaceuticals Receives FDA Approval for Zorvolex |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
